Categories: All postsCannabis

Green Thumb Industries has lots of upside, GMP Securities says

Actions speak louder than words and that holds for execution in the cannabis space as well, where US cannabis play Green Thumb Industries (Green Thumb Industries Stock Quote, Chart CSE:GTII) has just closed on the purchase of Nevada-based operator Integral Associates, doing business as Essence.

Remarking on the event, GMP Securities analyst Robert Fagan says it helps confirm GTII as one of the strongest operators in the cannabis space.

Essence —which currently operates three stores in the Las Vegas area, two production facilities in Nevada totaling approximately 95,000 square feet, eight additional licenses in NV as well as one in West Hollywood— represents a major win for GTI shareholders, says Green Thumb found and CEO Ben Kovler.

“Integral Associates is an exceptional operator—it is a highly admired and respected business and adds award-winning products, significant retail market share, and healthy EBITDA to our business. This acquisition is immediately accretive and an important milestone as we position GTII to scale in one of the only limited license adult use markets,” Kovler said in a press release.

Fagan is calling the impact of the event positive, saying that although Essence’s contributions have been factored into his GTII forecast, the company’s additional licenses in Nevada and California have not, and thus, there is potentially significant upside to follow.

“We note GTII has successfully acquired Essence without incurring delays, and one month earlier than we expected, in a state (NV) that is notoriously difficult to pass regulatory approval. We believe this further cements GTII’s strong execution track-record, supporting our view of the company being amongst the strongest operators in the industry,” said Fagan in a client update on Wednesday.

The analyst is reiterating his “Buy” rating and C$32.00 target for GTII, which represented a projected return of 107.8 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: gtii
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago